Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Alector stock in Canada

Own Alector shares in just a few minutes.

Alector (ALEC) is a leading biotechnology business based in the US. It opened the day at $39.6 after a previous close of $39.13. During the day the price has varied from a low of $35.57 to a high of $39.74. The latest price was $36.91 (25 minute delay). Alector is listed on the NASDAQ and employs 185 staff. All prices are listed in US Dollars.

How to buy shares in Alector

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALEC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Alector stock price (NASDAQ:ALEC)

Use our graph to track the performance of ALEC stocks over time.

Alector shares at a glance

Information last updated 2021-07-09.
Open$39.60
High$39.74
Low$35.57
Close$36.91
Previous close$39.13
Change $-2.22
Change % -5.6734%
Volume 1,414,530
Information last updated 2022-01-24.
52-week range$14.38 - $43.32
50-day moving average $20.59
200-day moving average $22.86
Wall St. target price$45.14
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Alector stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Alector price performance over time

Historical closes compared with the close of $36.91 from 2022-01-26

1 week (2022-01-20) 134.65%
1 month (2021-12-24) N/A
3 months (2021-10-25) 59.51%
6 months (2021-07-28) 36.91
1 year (2021-01-28) 120.10%
2 years (2020-01-28) 50.10%
3 years (2019-01-24) N/A
5 years (2017-01-24) N/A

Alector financials

Revenue TTM $197.9 million
Gross profit TTM $-135,771,000
Return on assets TTM -3.08%
Return on equity TTM -10.18%
Profit margin -16.62%
Book value $4.13
Market capitalisation $1.3 billion

TTM: trailing 12 months

Alector share dividends

We're not expecting Alector to pay a dividend over the next 12 months.

Alector share price volatility

Over the last 12 months, Alector's shares have ranged in value from as little as $14.38 up to $43.32. A popular way to gauge a stock's volatility is its "beta".

ALEC.US volatility(beta: 1.07)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alector's is 1.071. This would suggest that Alector's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Alector overview

Alector, Inc. , a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases.

Stocks similar to Alector

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site